Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.

ABSTRACT:

Background

Breast cancer is the most frequent cancer in women and remains the second leading cause of death in Western countries. It represents a heterogeneous group of diseases with diverse tumoral behaviour, treatment responsiveness and prognosis. While major progress in diagnosis and treatment has resulted in a decline in breast cancer-related mortality, some patients will relapse and prognosis in this cohort of patients remains poor. Treatment is determined according to tumor subtype; primarily hormone receptor status and HER2 expression. Menopausal status and site of disease relapse are also important considerations in treatment protocols.

Main body

Staging and repeated evaluation of patients with metastatic breast cancer are central to the accurate assessment of diseas

SUBMITTER: Lother D 

PROVIDER: S-EPMC10230813 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature